Role of Draksha Avaleha and ferrous sulphate in the Management of Iron Deficiency Aaemia

Nidana Panchatmaka Study Of Pandu Roga wrs to Iron Deficiency Anaemia and its Management with Drakshavaleha In Comparison to Ferrous Sulphate

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047512

Enrollment

Registered

2022-11-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: D509- Iron deficiency anemia, unspecified Health Condition 4: D509- Iron deficiency anemia, unspecified Health Condition 5: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individulas Who Comes Under The Criteria Of 16 to 60 Years 2.Blood Picture Presenting Either Microcytic Hypochromic Or Normocytic Hypochromic. 3.Anaemia In Pregnancy.

Exclusion criteria

Exclusion criteria: 1.Anaemia Resulting From Acute or Chronic Blood Loss (Mennorhagia, DUB, Haemorrhoids) 2.Anaemia Resulting From Underlying Chronic Disorder Like Rheumatoid arthritis, Uraemia,Other Systemic Disorder , Thalasemia , Diabetes Mellitus , Hepatic Anaemia Cirhossis, Malignancy, Sideroblastic Anaemia

Design outcomes

Primary

Measure	Time frame
Management Of Iron Deficiency Anaemia With Draksha Avaleha with its subjective and objective Criteria FulfillmentTimepoint: Within 8 weeks of trial	—

Secondary

Measure	Time frame
Complete Management and Relieve of symptoms of pandu rogaTimepoint: 8 weeks of trial	—

Countries

India

Contacts

Public ContactDr Kamini Spolia

RGGPG Ayurvedic college and Hospital paprola District Kangra

drrkmanglesh@gmail.com9816324204

Outcome results